Fastigium

Fastigium biotechnology will consist of improving the in vivo transfection of mRNA by optimizing the endocytosis of LNPs and the escape of mRNA from endosomes.

 Last news

photo labo 2

Messenger Biopharma launches the commercialization of its Nuntius biotechnology

posted October 10, 2024

Read More